Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To evaluate the efficacy and safety of omega-3 fatty acids for the maintaining HD vascular access patency in CKD patients. The following will be addressed. To determine whether the use of omega-3 fatty acids versus placebo or no treatment for dialysis patients is associated with a reduction in failure rates. To determine whether the use of omega-3 fatty acids versus placebo or no treatment for dialysis patients is associated with harmful effects.

Original languageEnglish
Article numberCD011353
JournalCochrane Database of Systematic Reviews
Volume2014
Issue number10
DOIs
Publication statusPublished - Oct 23 2014

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Omega-3 fatty acids for vascular access outcomes in patients with chronic kidney disease'. Together they form a unique fingerprint.

Cite this